A detailed history of Virtus Investment Advisers, Inc. transactions in Annexon, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 34,698 shares of ANNX stock, worth $109,298. This represents 0.03% of its overall portfolio holdings.

Number of Shares
34,698
Previous 36,399 4.67%
Holding current value
$109,298
Previous $70,000 18.57%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$1.38 - $2.73 $2,347 - $4,643
-1,701 Reduced 4.67%
34,698 $83,000
Q1 2025

May 14, 2025

BUY
$1.93 - $5.5 $70,250 - $200,194
36,399 New
36,399 $70,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $150M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Virtus Investment Advisers, Inc. Portfolio

Follow Virtus Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.